Vanderbilt Health Policy COVID-19 model finds evidence of flattening curve, recommends distancing policies continue
Apr. 9, 2020—Vanderbilt University Medical Center researchers have found evidence of the rate of COVID-19 infection slowing in Tennessee, which reduces the chance that the state will run out of hospital capacity for patients.
Apr. 9, 2020—A group of physicians, nurses and representatives from multiple areas throughout VUMC came up with a process in less than a week to safely and effectively sanitize used N95 respirators.
Apr. 9, 2020—The NCI program project grant is supporting multiple projects that aim to define fundamental biological principles about extracellular RNA signaling and the development and aggressiveness of colorectal cancer, the second leading cause of cancer death in the United States.
Apr. 9, 2020—The world’s No.1 ranked surgery journal, JAMA Surgery, has announced that a June 2019 study led by researchers at Vanderbilt University Medical Center was the journal’s top paper of the year as measured by Altmetric Attention Score.
Apr. 9, 2020—Sophie Katz, MD, MPH, is one of four early career infectious diseases physicians in the United States to receive the award, which provides $100,000 of funding support from the Centers for Disease Control and Prevention.
Apr. 8, 2020—High levels of stress and anxiety can be debilitating, especially for health care providers on the front lines of the COVID-19 pandemic. But there are ways they can protect themselves and their ability to provide the best and most compassionate care.
Apr. 8, 2020—Policy changes related to telemedicine that were quickly implemented during the novel coronavirus pandemic (COVID-19) have created opportunities for technology-based clinical evaluation, which serves to protect patients and providers alike, while conserving personal protective equipment (PPE).
Vanderbilt University Medical Center and AstraZeneca join forces to identify potential COVID-19 treatments
Apr. 8, 2020—Vanderbilt University Medical Center and the global biopharmaceutical company AstraZeneca have joined forces to identify candidates for antibody-based treatments that could protect people exposed to the 2019 novel coronavirus disease, COVID-19.
Apr. 8, 2020— by Craig Boerner Faced with a global pandemic of a virus previously unknown to humans, Vanderbilt University Medical Center (VUMC) is leading a clinical trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19. The ORCHID trial (Outcomes Related to...
Apr. 7, 2020—vumc2go, the new workforce app, is being updated frequently with features to make navigating the app and Vanderbilt University Medical Center easier. This page will be updated with guides on how to use the app’s growing list of features. Do you have ideas about features you would like to see? Email email@example.com. App features, in...